State Farm Reports a $1.2 Million GATX Purchase
In another eye-catching Form 4, director Robert Marshall disclosed the acquisition of 100,000 shares of Nuvation Bio Inc $NUVB, signaling serious confidence in the biotech space.
GATX has been stair-stepping higher, in a persistent uptrend for roughly a decade.
Price is currently coiling, as GATX digests some of its gains.
As long as we're above 109, the primary uptrend remains intact.
Have a great weekend. We'll be back on Monday with more insider activity.
And please reach out with any questions. We love hearing from you!
For questions about your membership, contact us at 323-421-7910 or info@stockmarketmedia.com